Showing results (31-40 of 149) with videos related to
Sort By:
Pageof 15
Blood|August 9, 2003
Human dendritic cells express neuronal Eph receptor tyrosine kinases: role of EphA2 in regulating adhesion to fibronectinBlandine de Saint-Vis, Caroline Bouchet, Gregory Gautier, et al.Oncoimmunology|August 31, 2012
Innate immune recognition of breast tumor cells mediates CCL22 secretion favoring Treg recruitment within tumor environmentChristine Ménétrier-Caux, Julien Faget, Cathy Biota, et al.Oncoimmunology|June 27, 2013
ICOS is associated with poor prognosis in breast cancer as it promotes the amplification of immunosuppressive CD4+ T cells by plasmacytoid dendritic cellsJulien Faget, Vanja Sisirak, Jean-Yves Blay, et al.Frontiers in Immunology|June 28, 2019
Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell FunctionSelena Vigano, Dimitrios Alatzoglou, Melita Irving, et al.Critical Reviews in Oncology/Hematology|December 5, 2020
Neoadjuvant immune checkpoint inhibitors in cancer, current state of the artOlivia Le Saux, Yasmine Lounici, Pauline Wajda, et al.Cancers|October 14, 2022
Heterogeneity and Functions of Tumor-Infiltrating Antibody Secreting Cells: Lessons from Breast, Ovarian, and Other Solid CancersYasmine Lounici, Olivia Le Saux, Gabriel Chemin, et al.Oncoimmunology|March 14, 2013
Plasmacytoid dendritic cells deficient in IFNα production promote the amplification of FOXP3+ regulatory T cells and are associated with poor prognosis in breast cancer patientsVanja Sisirak, Julien Faget, Nelly Vey, et al.Cancer Immunology, Immunotherapy : CII|September 20, 2008
Paclitaxel reduces regulatory T cell numbers and inhibitory function and enhances the anti-tumor effects of the TLR9 agonist PF-3512676 in the mouseAlain P Vicari, Rachel Luu, Ningli Zhang, et al.Blood|January 15, 2005
Fc receptor gamma-chain activation via hOSCAR induces survival and maturation of dendritic cells and modulates Toll-like receptor responsesEstelle Merck, Blandine de Saint-Vis, Mathieu Scuiller, et al.Journal of Immunology Research|December 15, 2015
In Vitro and In Vivo Comparison of Lymphocytes Transduced with a Human CD16 or with a Chimeric Antigen Receptor Reveals Potential Off-Target Interactions due to the IgG2 CH2-CH3 CAR-SpacerBéatrice Clémenceau, Sandrine Valsesia-Wittmann, Anne-Catherine Jallas, et al.Pageof 15